The Innovation Agency (Academic Health Science Network for the North West Coast) has been one of a number of organisations to deliver improvements in care for people with AF across a healthcare system.
In 2015, the AHSN Network set ambitious targets to systematically improve the detection, diagnosis and treatment of patients with AF. At this time the North West Coast’s baseline data (QOF 15/16) showed that:
• 24,210 people were estimated to have undetected AF.
• 76% of people with high risk AF were treated with an anticoagulation therapy (AT).
The Innovation Agency was keen to ensure that local best practice was understood and promoted, whilst acknowledging that sustainable improvements in the outcomes for patients with AF would require greater collaboration and integrated system working.